HK1202118A1 - 治療癌症的哌嗪基衍生物 - Google Patents
治療癌症的哌嗪基衍生物Info
- Publication number
- HK1202118A1 HK1202118A1 HK15102598.5A HK15102598A HK1202118A1 HK 1202118 A1 HK1202118 A1 HK 1202118A1 HK 15102598 A HK15102598 A HK 15102598A HK 1202118 A1 HK1202118 A1 HK 1202118A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- treatment
- piperazinyl derivatives
- piperazinyl
- derivatives
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 125000004193 piperazinyl group Chemical group 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1162586A FR2985256B1 (fr) | 2011-12-30 | 2011-12-30 | Derives piperazinyles pour le traitement de cancers |
| PCT/EP2012/077059 WO2013098393A1 (fr) | 2011-12-30 | 2012-12-28 | Derives piperazinyles pour le traitement de cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1202118A1 true HK1202118A1 (zh) | 2015-09-18 |
Family
ID=47470025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15102598.5A HK1202118A1 (zh) | 2011-12-30 | 2015-03-13 | 治療癌症的哌嗪基衍生物 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9321778B2 (zh) |
| EP (1) | EP2797898B9 (zh) |
| JP (1) | JP6105625B2 (zh) |
| KR (1) | KR102086732B1 (zh) |
| CN (1) | CN104053648B (zh) |
| AU (1) | AU2012360815B2 (zh) |
| BR (1) | BR112014015991B1 (zh) |
| CA (1) | CA2859721C (zh) |
| ES (1) | ES2606289T3 (zh) |
| FR (1) | FR2985256B1 (zh) |
| HK (1) | HK1202118A1 (zh) |
| HU (1) | HUE030951T2 (zh) |
| IL (1) | IL233414A (zh) |
| PL (1) | PL2797898T3 (zh) |
| RU (1) | RU2629115C2 (zh) |
| SG (1) | SG11201403727YA (zh) |
| WO (1) | WO2013098393A1 (zh) |
| ZA (1) | ZA201405068B (zh) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10358539A1 (de) * | 2003-12-15 | 2005-07-07 | Merck Patent Gmbh | Carbonsäureamidderivate |
| US20060058296A1 (en) * | 2003-12-24 | 2006-03-16 | Scios, Inc. | Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase |
| WO2005110994A2 (en) * | 2004-04-30 | 2005-11-24 | Bayer Pharmaceuticals Corporation | Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| US7615556B2 (en) * | 2006-01-27 | 2009-11-10 | Bristol-Myers Squibb Company | Piperazinyl derivatives as modulators of chemokine receptor activity |
| ES2369596T3 (es) * | 2007-05-04 | 2011-12-02 | Astrazeneca Ab | Derivados de amino-tiazolil-pirimidina y su uso para el tratamiento del cáncer. |
| FR2932483A1 (fr) * | 2008-06-13 | 2009-12-18 | Cytomics Systems | Composes utiles pour le traitement des cancers. |
| WO2010091164A1 (en) * | 2009-02-06 | 2010-08-12 | Exelixis, Inc. | Inhibitors of glucosylceramide synthase |
| EA201101650A1 (ru) * | 2009-05-21 | 2012-07-30 | Астразенека Аб | Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний |
| MX342951B (es) * | 2010-07-16 | 2016-10-18 | Agios Pharmaceuticals Inc * | Composiciones terapeuticamente activas y su metodo de uso. |
| WO2012129452A2 (en) | 2011-03-22 | 2012-09-27 | University Of Southern California | Propynoic acid carbamoyl methyl-almides and pharmaceutical compositions and methods based thereon |
-
2011
- 2011-12-30 FR FR1162586A patent/FR2985256B1/fr active Active
-
2012
- 2012-12-28 CA CA2859721A patent/CA2859721C/fr active Active
- 2012-12-28 BR BR112014015991-2A patent/BR112014015991B1/pt active IP Right Grant
- 2012-12-28 EP EP12808851.5A patent/EP2797898B9/fr active Active
- 2012-12-28 RU RU2014131001A patent/RU2629115C2/ru active
- 2012-12-28 WO PCT/EP2012/077059 patent/WO2013098393A1/fr active Application Filing
- 2012-12-28 US US14/369,407 patent/US9321778B2/en active Active
- 2012-12-28 ES ES12808851.5T patent/ES2606289T3/es active Active
- 2012-12-28 AU AU2012360815A patent/AU2012360815B2/en active Active
- 2012-12-28 PL PL12808851T patent/PL2797898T3/pl unknown
- 2012-12-28 CN CN201280064255.3A patent/CN104053648B/zh active Active
- 2012-12-28 KR KR1020147021126A patent/KR102086732B1/ko active IP Right Grant
- 2012-12-28 JP JP2014549488A patent/JP6105625B2/ja active Active
- 2012-12-28 SG SG11201403727YA patent/SG11201403727YA/en unknown
- 2012-12-28 HU HUE12808851A patent/HUE030951T2/en unknown
-
2014
- 2014-06-26 IL IL233414A patent/IL233414A/en active IP Right Grant
- 2014-07-11 ZA ZA2014/05068A patent/ZA201405068B/en unknown
-
2015
- 2015-03-13 HK HK15102598.5A patent/HK1202118A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012360815B2 (en) | 2017-02-02 |
| BR112014015991A2 (pt) | 2017-06-13 |
| JP2015505308A (ja) | 2015-02-19 |
| FR2985256A1 (fr) | 2013-07-05 |
| IL233414A (en) | 2015-11-30 |
| EP2797898A1 (fr) | 2014-11-05 |
| SG11201403727YA (en) | 2014-09-26 |
| NZ627149A (en) | 2015-08-28 |
| ES2606289T3 (es) | 2017-03-23 |
| CN104053648A (zh) | 2014-09-17 |
| AU2012360815A1 (en) | 2014-07-31 |
| FR2985256B1 (fr) | 2016-03-04 |
| BR112014015991B1 (pt) | 2022-11-16 |
| CA2859721A1 (fr) | 2013-07-04 |
| JP6105625B2 (ja) | 2017-03-29 |
| KR102086732B1 (ko) | 2020-03-09 |
| US20140356360A1 (en) | 2014-12-04 |
| WO2013098393A1 (fr) | 2013-07-04 |
| CN104053648B (zh) | 2016-09-28 |
| RU2014131001A (ru) | 2016-02-20 |
| HUE030951T2 (en) | 2017-06-28 |
| RU2629115C2 (ru) | 2017-08-24 |
| EP2797898B9 (fr) | 2021-05-26 |
| BR112014015991A8 (pt) | 2017-07-04 |
| KR20140117456A (ko) | 2014-10-07 |
| PL2797898T3 (pl) | 2017-03-31 |
| IL233414A0 (en) | 2014-08-31 |
| US9321778B2 (en) | 2016-04-26 |
| CA2859721C (fr) | 2020-01-07 |
| EP2797898B1 (fr) | 2016-09-14 |
| ZA201405068B (en) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254859A1 (zh) | 治療乳腺癌的方法 | |
| HK1201256A1 (zh) | 用於治療癌症的吡咯並嘧啶化合物 | |
| HK1206338A1 (zh) | 用於治療癌症的嘧啶化合物 | |
| HK1202253A1 (zh) | 癌症的聯合治療 | |
| EP2925752A4 (en) | PYRIMIDINE COMPOUNDS FOR CANCER TREATMENT | |
| EP2830633A4 (en) | COMBINATION THERAPY FOR CANCER TREATMENT | |
| HK1185874A1 (zh) | 用於治療癌症的新的 -氨基- -羥基-苯甲酰胺 | |
| IL228430A0 (en) | Cancer treatment | |
| HK1204605A1 (zh) | 用於治療癌症的功能化的噻吩並吲哚衍生物 | |
| IL275636A (en) | Medical combination for cancer treatment | |
| HK1223832A1 (zh) | 用於癌症治療的激酶抑制劑 | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| IL233493A (en) | Imidazopyridine derivatives for cancer treatment | |
| IL236870B (en) | History of hydroxystatin for the treatment of osteoarthritis | |
| HK1202118A1 (zh) | 治療癌症的哌嗪基衍生物 | |
| HK1200094A1 (zh) | 免疫調節劑用於治療癌症的用途 | |
| HUE048942T2 (hu) | Antraciklin-származékok tumorbetegségek kezeléséhez | |
| EP2750691A4 (en) | SRPX IN THE TREATMENT OF CANCER | |
| GB201121791D0 (en) | Combination treatment of cancer | |
| GB201121783D0 (en) | Treatment of cancer | |
| AU2012901199A0 (en) | Kinase inhibitors for the Treatment of Cancer |